复发性耐火性多发性髓瘤的管理:为社区瘤学家提供基于证据的指南
Ali Mushtaq1, Asfand Yar Cheema1, Hossam M Ali2
1Department of Internal Medicine, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, USA.
Blood reviews
|September 30, 2025
概括
本综述指导临床医生针对早期复发性/耐药性多发性骨髓瘤 (RRMM) 个性化治疗. 它涵盖了患者因素,新疗法,如CAR T细胞,以及改善结果的决策框架.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 临床治疗学 临床治疗学
背景情况:
- 多发性骨髓瘤 (MM) 是一种血细胞恶性瘤,具有治疗挑战,特别是在复发性/耐药性病例 (RRMM) 中.
- 早期复发 (1-3次前期治疗) 需要量身定制的治疗策略,以获得最佳的患者结果.
研究的目的:
- 提供专注于临床医生的指南,用于在RRMM早期个性化,基于证据的治疗选择.
- 审查当前和新兴的新疗法及其疗效和安全性概况.
- 为RRMM管理中的临床决策提供一个实际的框架.
主要方法:
- 审查当前的临床文献和重点临床试验,重点关注疗效和安全.
- 分析患者相关因素,疾病特征和先前治疗反应.
- 评估新型治疗药物,包括单克隆抗体,CAR T细胞和双特异性抗体.
主要成果:
- 个性化治疗选择受患者的脆弱性,并发症,疾病风险和先前治疗反应的影响.
- 新型药物如抗CD38抗体,BCMA导向疗法 (CAR T细胞) 和双特异性抗体显示出转化潜力.
- 关键的临床试验显示了不同的疗效 (反应率,PFS,OS) 和安全性 (CRS,神经毒性,感染).
结论:
- 一个实用的框架有助于选择早期RRMM的组合疗法和免疫疗法平台.
- 在BCMA导向治疗后复发的管理和救援策略至关重要.
- 未来的方向包括下一代细胞疗法,新型抗体和CELMODs来增强免疫疗法.
更多相关视频
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
13.5K
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
30.4K
相关概念视频
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
01:22Myocarditis IV: Nursing Management
207
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
207
01:20Myasthenia Gravis: Overview and Treatment
2.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.8K
01:21Rheumatic Heart Disease III: Medical Management
289
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
289
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
01:21Cancer Survival Analysis
648
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
648